According to the available data, among individuals affected with NKX2-1-related disorders, 50% had the full brain-lung-thyroid syndrome, 30% brain and thyroid involvement, and 13% chorea only (Carré et al. 2009; Parnes et al. 2019). This evidence concerns the gene NKX2-1 and choreatic disease.